Melatonin for Sleep and Recovery: What Lifters Need to Know

Melatonin is the best-selling sleep supplement in the United States and one of the most consistently misused. It sits on shelves in 5 mg and 10 mg gummies next to the vitamins, gets swallowed twenty minutes before bed, and gets judged by whether it knocked you out. When it does not, people double the dose, which makes the problem worse.

The confusion comes from a category error. Melatonin is not a sedative. Your brain does not use it to shut down; it uses it to announce that darkness has started. Every one of the practical rules below -- why less works better than more, why 3 hours before bed beats 20 minutes before bed, why it obliterates jet lag but barely moves ordinary insomnia -- follows from that one fact.

We have already made the case that sleep is the largest recovery lever a lifter controls, larger than any supplement on this site. This article is the supplement-specific layer underneath it: what dose, what time, what the research actually found, and where melatonin is the wrong tool entirely.

What Melatonin Actually Does

Melatonin is a hormone produced by the pineal gland, a pea-sized structure near the center of the brain. Its production is governed by the suprachiasmatic nucleus, the hypothalamic cluster that serves as your master circadian clock. Light hitting specialized retinal cells suppresses melatonin release. Darkness permits it. Under normal conditions, output begins climbing roughly 2 hours before your habitual bedtime -- a moment researchers call dim light melatonin onset, or DLMO -- peaks in the middle of the night, and falls to near zero by morning.

Nighttime peak concentrations in a healthy adult run somewhere in the range of 50-200 picograms per milliliter of blood. Hold that number, because it is the entire argument about dosing. A 0.3 mg oral dose reproduces roughly that physiological range. A 10 mg gummy produces blood levels that can exceed the natural peak by a factor in the dozens, sustained well past sunrise.

Functionally, melatonin does two separable things:

• A mild soporific effect. It slightly reduces core body temperature and promotes drowsiness, which shortens the time it takes to fall asleep. This effect is real and modest.
• A chronobiotic effect. It tells the circadian system what time it is, and depending on when you take it relative to your own clock, it shifts that clock earlier or later. This effect is the strong one, and it is the one almost nobody uses on purpose.

Most people buy melatonin for the first effect and never touch the second. That is like buying a barbell and only using it for calf raises.

The Dose Problem: Why 10 mg Is Not Better

The classic dosing study is Zhdanova and colleagues, published in the Journal of Clinical Endocrinology & Metabolism in 2001. Adults over 50 with insomnia received 0.1 mg, 0.3 mg, or 3.0 mg of melatonin. The 0.3 mg physiological dose restored sleep efficiency and brought plasma melatonin back into the normal nocturnal range. The 3.0 mg pharmacological dose also improved sleep, but it induced hypothermia and left plasma melatonin elevated into daylight hours -- the biochemical version of your body being told it is still night at 9 a.m.

That is the mechanism behind melatonin hangover. Grogginess the morning after is not the supplement being strong. It is the supplement still being in your bloodstream telling your clock the wrong time.

A 2024 systematic review and dose-response meta-analysis by Cruz-Sanabria and colleagues in the Journal of Pineal Research, pooling 26 randomized controlled trials and 1,689 observations, mapped the curve directly. Reductions in sleep onset latency and increases in total sleep time improved with dose and then plateaued at roughly 4 mg per day. Above that, the curve flattens. Nothing in the pooled data suggests 10 mg outperforms 4 mg, and the pharmacokinetics suggest it costs you morning alertness.

The commercial market runs backwards from this. Walk into any pharmacy and the shelf skews heavily toward 5 mg and 10 mg, because a consumer who feels nothing from 0.5 mg buys the bigger number next time, and because a supplement company cannot patent a dose but can absolutely market one. Finding 0.3 mg tablets often means ordering online. That is a marketing outcome, not a scientific one.

What the Sleep Data Actually Shows

Here is the number that should calibrate your expectations. Ferracioli-Oda and colleagues meta-analyzed 19 studies covering 1,683 subjects with primary sleep disorders. Melatonin reduced sleep onset latency by 7.06 minutes (95% CI 4.37 to 9.75) and increased total sleep time by 8.25 minutes (95% CI 1.74 to 14.75) compared with placebo.

Both effects are statistically significant. Both are also small. Seven minutes is a genuine improvement if you spend 45 minutes staring at the ceiling, and it is nothing like the effect of a prescription hypnotic. Any product page implying melatonin will reliably put you out is describing a drug that does not exist.

The American Academy of Sleep Medicine's 2017 clinical practice guideline on pharmacologic treatment of chronic insomnia recommended against melatonin for sleep onset or sleep maintenance insomnia in adults, a weak recommendation based on low-quality evidence. That is a specific verdict about a specific condition, and it is worth separating from melatonin's stronger showing in circadian rhythm disorders, where the AASM's separate guidance is considerably more favorable.

So melatonin is weak medicine for ordinary insomnia and useful medicine for a mistimed clock. If you are lying awake because work stress is running laps in your head, or because you had a pre-workout at 5 p.m. and its 5-6 hour half-life is still doing its job at midnight, melatonin is treating the wrong variable. Sort the caffeine cutoff first. It is free and the effect size is bigger.

Melatonin is measured in minutes. A caffeine cutoff, a consistent wake time, and a dark cool room are measured in hours. Fix the free variables before you buy the bottle.

Timing: Two Different Jobs, Two Different Clocks

Most people take melatonin 15-30 minutes before bed, which is how you would take a sleeping pill. The research points somewhere else, and the right answer depends on which of melatonin's two effects you want.

If you want to fall asleep faster tonight

The Cruz-Sanabria dose-response meta-analysis found that taking melatonin 2-3 hours before the sleep episode produced significantly greater reductions in sleep onset latency than taking it immediately before bed, with the 3-hour interval outperforming the 2-hour one. Pooling their dose and timing findings, the optimum in the trial data was roughly 4 mg taken about 3 hours before bedtime.

The logic is straightforward once you stop treating it as a sedative. You are trying to bring forward your DLMO -- the moment your own melatonin starts rising -- not to chemically switch off your cortex. Nudging that signal earlier requires being ahead of it, and an immediate-release melatonin tablet peaks in blood roughly 30-60 minutes after ingestion with a short half-life measured in tens of minutes, so a dose taken as your head hits the pillow arrives after your endogenous rise has already begun.

If you want to move your clock

This is where melatonin's phase response curve matters. Burgess and colleagues generated PRCs for both 0.5 mg and 3.0 mg doses and found the maximum phase advance -- pulling your clock earlier -- when melatonin was taken roughly 2-4 hours before DLMO, or about 9-11 hours before the midpoint of your sleep. For someone sleeping midnight to 8 a.m., sleep midpoint is 4 a.m., which puts the optimal advance window somewhere around 5-7 p.m.

Two details from that work matter for anyone buying melatonin. First, the 0.5 mg PRC was comparable in magnitude to the 3.0 mg PRC, which means you do not need a big dose to shift your clock. Second, taking melatonin in the morning shifts your clock later, which is the opposite of what most people want and a real risk if you take it after a middle-of-the-night wake-up.

Recovery, Growth Hormone, and Performance

The lifting-specific claims for melatonin cluster around three ideas: it boosts growth hormone, it improves recovery through antioxidant activity, and it improves performance. The evidence quality drops sharply from left to right.

The growth hormone claim

Melatonin does interact with GH secretion. Human work going back to Valcavi and colleagues in the early 1990s showed melatonin administration can enhance growth hormone response, likely through effects on hypothalamic somatostatin tone. That is a real finding and it is also where most supplement marketing stops reading.

What it does not establish is that this translates into muscle. The bulk of nightly GH release is tied to slow-wave sleep, which is why sleep deprivation flattens the GH pulse in the first place. Modest pharmacological bumps in GH in a healthy adult have never been shown to produce meaningful changes in lean mass or strength, and the entire "GH booster" supplement category rests on that unfilled gap between a hormone graph and a body composition outcome. Treat the melatonin-GH connection as interesting physiology, not as an anabolic strategy.

The recovery and antioxidant claim

This one has better support, with real caveats. Melatonin is a potent direct free radical scavenger and stimulates endogenous antioxidant enzymes. Systematic reviews of melatonin supplementation in highly trained athletes report improvements in antioxidant status and inflammatory markers, and reductions in circulating markers of exercise-induced muscle damage such as creatine kinase and lactate dehydrogenase. A 2025 timing-focused meta-analysis found effects on muscle damage markers were clearest with evening administration and adequate spacing before exercise, and reported greater improvements at lower doses in the 6-10 mg range than at the very high doses (up to 100 mg) some protocols used.

Two honest caveats. First, lower creatine kinase does not automatically mean faster functional recovery; blood markers and next-session performance are related but not interchangeable. Second, there is a live debate about whether blunting exercise-induced oxidative stress blunts the adaptation signal along with it, the same argument that applies to high-dose antioxidant vitamins and to post-workout cold plunges. Reactive oxygen species are part of how your muscle knows it was trained.

The performance claim

This one is close to settled and the answer is no. Reviews of randomized trials in trained athletes consistently find melatonin does not improve strength, power, sprint performance, or short-duration continuous exercise. Some endurance-context signals exist, mostly indirect and mostly plausible as downstream effects of better sleep rather than direct ergogenic action. There is also a straightforward practical reason not to take melatonin near training: it lowers core temperature and promotes drowsiness, which is the opposite of what you want before a heavy session.

The Dependency Myth

The most common objection to melatonin is that your body will stop making its own or that you will become dependent. Neither claim survives contact with the evidence.

On endogenous suppression: there is no good human evidence that short-term or moderate-term supplementation downregulates pineal melatonin production. Melatonin synthesis is driven by the light-dark cycle via the suprachiasmatic nucleus, not by a classic negative feedback loop like the hypothalamic-pituitary-gonadal axis, where exogenous testosterone genuinely does shut down your own production. The comparison people reach for does not apply here.

On dependence and withdrawal: melatonin is not a controlled substance, does not act on the GABA-A receptor the way benzodiazepines and Z-drugs do, and does not produce the tolerance, escalation, or rebound insomnia pattern those drugs are known for. Safety reviews of controlled trials, including the Buscemi analyses commissioned for the US Agency for Healthcare Research and Quality, found adverse events comparable to placebo over the durations studied, with no withdrawal syndrome.

What people experience as dependency is usually one of three things. It is expectancy -- you sleep badly the first night without it because you are watching for it. It is an unaddressed underlying cause that melatonin was papering over, which reappears the moment you stop. Or it is that melatonin had become a load-bearing part of a bedtime routine, and removing any part of a routine costs you a night or two.

What is genuinely under-studied is long-term use. Most trials run weeks to a few months. Nightly use for years has not been characterized well, particularly in adolescents where melatonin's interaction with reproductive development remains an open question. "No evidence of harm" is not the same as "evidence of no harm," and the honest position on multi-year daily use is that nobody knows.

Jet Lag and Shift Work: Where It Earns Its Keep

Everything above makes melatonin sound marginal. For travel, it is not. The Cochrane review by Herxheimer and Petrie assessed melatonin for jet lag across ten trials and concluded it was remarkably effective at preventing or reducing jet lag, with an estimated number needed to treat of 2. In a supplement world where most things need dozens of people treated to help one, an NNT of 2 is exceptional.

The review's dosing conclusion is worth quoting in substance: doses between 0.5 mg and 5 mg were similarly effective, except that people fell asleep faster and slept better on 5 mg than 0.5 mg. Doses above 5 mg were no more effective. Taking it at the destination's bedtime for two to five days after arrival was the protocol that worked.

Direction of travel changes the difficulty. Eastward flights require phase advances -- going to bed earlier than your body wants -- and phase advances are the harder direction because the human circadian period runs slightly longer than 24 hours. Melatonin helps most here. Westward flights require phase delays, which your body handles more easily on its own, and evening melatonin can actually work against you by advancing a clock you are trying to delay.

One point that gets lost: melatonin is a supporting actor to light. Light exposure is the dominant zeitgeber, and it is free. Morning bright light after an eastward flight, and aggressive darkness in the hours before your target bedtime, will do more for your clock than any tablet. Melatonin makes those interventions work faster. It does not replace them.

What Is Actually in the Bottle

Melatonin is regulated in the United States as a dietary supplement, which means no premarket approval of potency or purity. In the United Kingdom, most of the European Union, Australia, Canada, and Japan, it is a prescription or pharmacist-controlled medicine. Same molecule, wildly different quality control.

The consequences got measured. Erland and Saxena analyzed 31 commercial melatonin products from 16 brands by ultra-performance liquid chromatography and published the results in the Journal of Clinical Sleep Medicine. More than 70% of products missed their label claim by more than 10%. Actual melatonin content ranged from 83% below to 478% above what the label stated. Variability between lots of the same product from the same brand reached 465%. And serotonin, a tightly controlled compound with real interaction risks, showed up in 26% of the samples.

That last finding is the one that should change behavior. A mislabeled dose in a supplement whose effective range spans 0.3 mg to 5 mg is not a rounding error. If your 3 mg tablet is actually 14 mg, you have a morning grogginess problem you will never diagnose from the bottle.

The pediatric side of this deserves a mention because it explains why melatonin regulation is being reconsidered. A CDC analysis published in MMWR found pediatric melatonin ingestions reported to US poison control centers rose 530% between 2012 and 2021, from 8,337 to 52,563 annually, totaling more than 260,000 over the decade. Most were unintentional ingestions by children under five, and gummies that look and taste like candy are the obvious mechanism. If melatonin is in your house, treat it like medication, not like a snack.

Side Effects, Interactions, and Who Should Skip It

Melatonin's short-term safety profile is genuinely good. Reported adverse events in controlled trials run close to placebo. The most common complaints are dose-dependent and predictable: morning grogginess, headache, vivid or unusually intense dreams, mild dizziness, and daytime sleepiness. Nearly all of them improve when you lower the dose, which is worth trying before concluding you cannot tolerate it.

The interactions that matter:

• Anticoagulants and antiplatelet drugs. Melatonin may affect coagulation. If you take warfarin or similar, clear it with your doctor.
• Blood pressure medication. Effects on nocturnal blood pressure have been reported in both directions across studies.
• Fluvoxamine and other CYP1A2 inhibitors. These can dramatically raise melatonin blood levels from the same oral dose. So can quitting smoking, since tobacco smoke induces CYP1A2.
• Immunosuppressants. Melatonin has immunomodulatory activity, which is a theoretical concern for transplant patients and people on immunosuppressive therapy.
• Other sedatives and alcohol. Additive drowsiness, and alcohol already wrecks sleep architecture on its own.

One interaction is specific enough to be worth its own paragraph for lifters who eat late. Rubio-Sastre and colleagues found acute melatonin administration impaired glucose tolerance in healthy adults, in both morning and evening testing. Follow-up work from the same research groups showed that eating close to elevated melatonin levels raised post-meal glucose and lowered insulin response, with a considerably stronger effect in carriers of the common MTNR1B risk variant, a genotype present in roughly half of people of European ancestry. The practical translation is simple: put at least 2-3 hours between your last substantial meal and your melatonin dose. If you are a late-night eater who takes melatonin right after a big meal, you are stacking two glucose challenges on top of each other.

Who should skip melatonin without medical guidance: anyone pregnant or breastfeeding, anyone with an autoimmune condition, anyone on the medications above, and children and adolescents outside of clinical supervision. Also anyone whose sleep problem includes loud snoring, witnessed breathing pauses, or crushing daytime sleepiness despite adequate time in bed -- that pattern points toward sleep apnea, and a supplement that adds drowsiness to an untreated airway problem is not a solution.

Protocols: How to Actually Use It

Everything above condenses into a short set of rules.

Before you buy anything

Fix the free variables first, because they outperform melatonin by a wide margin and cost nothing:

• Cut caffeine 8-10 hours before bed. A 300 mg pre-workout at 4 p.m. leaves roughly a cup of coffee in your system at midnight.
• Hold a consistent wake time, including weekends. Wake time anchors the circadian system more powerfully than bedtime does.
• Get bright light in your eyes within an hour of waking and dim your environment aggressively in the last 2 hours before bed.
• Keep the room cool and genuinely dark. Core temperature has to fall for sleep onset.
• Stop drinking alcohol as a sleep aid. It shortens sleep latency and then fragments the second half of the night.

If you have run all of that for a few weeks and still have a problem, melatonin becomes a reasonable next step. If you have not, melatonin is a 7-minute patch on a 2-hour problem.

The standard protocol

1. Start at 0.5 mg. Not 5 mg. Not 10 mg. Split a 1 mg tablet if that is what you can find.
2. Take it 2-3 hours before your target bedtime, not at bedtime. This is the single most impactful change most people can make.
3. Keep it away from food. Aim for 2-3 hours after your last substantial meal.
4. Give it 5-7 nights before judging it. Circadian shifts accumulate; a single night tells you very little.
5. Escalate only if 0.5 mg does nothing, and only to 1-3 mg. There is essentially no case for exceeding 5 mg.
6. If you wake up groggy, cut the dose in half rather than abandoning it. Grogginess is a carryover problem.
7. Use it in blocks, not forever. Travel weeks, schedule resets, deload periods after a run of bad nights. Long-term nightly use has not been well studied and there is no reason to be the experiment.

The Bottom Line

Melatonin is a well-studied hormone sold in doses roughly ten to thirty times higher than the physiology calls for, marketed for the weaker of its two effects, and taken at the wrong time by almost everyone who buys it. Fix those three things and it becomes a genuinely useful tool.

Use 0.3-0.5 mg as your starting point and treat 5 mg as a ceiling, because the pooled dose-response data plateaus around 4 mg and the extra you take past that shows up as morning fog rather than sleep. Take it 2-3 hours before bed rather than at bedtime. Expect roughly 7 minutes off your sleep latency for ordinary use, and expect far more than that when you deploy it against a mistimed clock -- jet lag, night shifts, a schedule that has drifted to 2 a.m. It is not addictive, it does not shut down your own production, and the fear-based objections to it are mostly borrowed from drug classes it has nothing in common with.

For recovery specifically, be clear about the causal chain. Melatonin does not build muscle, does not meaningfully raise growth hormone in any way that shows up in a mirror, and does not improve strength or power in trained athletes. What it can do is help you get to sleep on schedule, and sleep is where the recovery happens. That is a real contribution and it is a modest one. If you want the biggest available lever on recovery, it remains the boring one: eight hours, same time every night, in a dark cool room, without caffeine or alcohol in your bloodstream. Melatonin is a tool for getting your clock pointed at that target. It is not a substitute for hitting it.

References

1. Zhdanova, I.V., Wurtman, R.J., Regan, M.M., Taylor, J.A., Shi, J.P., & Leclair, O.U. (2001). Melatonin treatment for age-related insomnia. Journal of Clinical Endocrinology & Metabolism, 86(10), 4727-4730.
2. Ferracioli-Oda, E., Qawasmi, A., & Bloch, M.H. (2013). Meta-analysis: melatonin for the treatment of primary sleep disorders. PLoS ONE, 8(5), e63773.
3. Cruz-Sanabria, F., et al. (2024). Optimizing the time and dose of melatonin as a sleep-promoting drug: a systematic review of randomized controlled trials and dose-response meta-analysis. Journal of Pineal Research, 76(5), e12985.
4. Burgess, H.J., Revell, V.L., Molina, T.A., & Eastman, C.I. (2010). Human phase response curves to three days of daily melatonin: 0.5 mg versus 3.0 mg. Journal of Clinical Endocrinology & Metabolism, 95(7), 3325-3331.
5. Burgess, H.J., Revell, V.L., & Eastman, C.I. (2008). A three pulse phase response curve to three milligrams of melatonin in humans. Journal of Physiology, 586(2), 639-647.
6. Herxheimer, A., & Petrie, K.J. (2002). Melatonin for the prevention and treatment of jet lag. Cochrane Database of Systematic Reviews, (2), CD001520.
7. Erland, L.A.E., & Saxena, P.K. (2017). Melatonin natural health products and supplements: presence of serotonin and significant variability of melatonin content. Journal of Clinical Sleep Medicine, 13(2), 275-281.
8. Lelak, K., Vohra, V., Neuman, M.I., Farooqi, A., & Toce, M.S. (2022). Pediatric melatonin ingestions -- United States, 2012-2021. MMWR Morbidity and Mortality Weekly Report, 71(22), 725-729.
9. Sateia, M.J., Buysse, D.J., Krystal, A.D., Neubauer, D.N., & Heald, J.L. (2017). Clinical practice guideline for the pharmacologic treatment of chronic insomnia in adults: an American Academy of Sleep Medicine clinical practice guideline. Journal of Clinical Sleep Medicine, 13(2), 307-349.
10. Buscemi, N., et al. (2006). Efficacy and safety of exogenous melatonin for secondary sleep disorders and sleep disorders accompanying sleep restriction: meta-analysis. BMJ, 332(7538), 385-393.
11. Rubio-Sastre, P., Scheer, F.A.J.L., Gomez-Abellan, P., Madrid, J.A., & Garaulet, M. (2014). Acute melatonin administration in humans impairs glucose tolerance in both the morning and evening. Sleep, 37(10), 1715-1719.
12. Garaulet, M., et al. (2022). Interplay of dinner timing and MTNR1B type 2 diabetes risk variant on glucose tolerance and insulin secretion: a randomized crossover trial. Diabetes Care, 45(3), 512-519.
13. Valcavi, R., Zini, M., Maestroni, G.J., Conti, A., & Portioli, I. (1993). Melatonin stimulates growth hormone secretion through pathways other than the growth hormone-releasing hormone. Clinical Endocrinology, 39(2), 193-199.
14. Corrales-Hernandez, M.G., et al. (2024). Impact of melatonin supplementation on sports performance and circulating biomarkers in highly trained athletes: a systematic review of randomized controlled trials. Nutrients, 16(7), 1011.
15. Lopez-Flores, M., et al. (2023). The effects of melatonin supplementation on professional football player performance: a systematic review. Nutrients, 15(20), 4467.
16. Reiter, R.J., Tan, D.X., Rosales-Corral, S., & Manchester, L.C. (2013). The universal nature, unequal distribution and antioxidant functions of melatonin and its derivatives. Mini Reviews in Medicinal Chemistry, 13(3), 373-384.